Metabolic disorder could lead to ROS production in hepatocytes and engender cell damage markers such as an increase in transaminase enzymes, for example alanine aminotransferase (ALT) and aspartate aminotransferase (AST). This evidence concerns the gene GPT and Other metabolic disease.